{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:04:15Z","timestamp":1779296655252,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ijantimicag.2014.05.020","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T16:37:05Z","timestamp":1405528625000},"page":"295-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: Extended-spectrum \u03b2-lactamases and the role of fosfomycin"],"prefix":"10.1016","volume":"44","author":[{"given":"Michael","family":"Kresken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-9386","authenticated-orcid":false,"given":"Dieter","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Wresch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"K\u00f6rber-Irrgang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2014.05.020_bib0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections: disease panorama and challenges","volume":"183","author":"Stamm","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0010","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","article-title":"Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy","volume":"54","author":"Naber","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO\u00b7SENS study revisited","volume":"39","author":"Kahlmeter","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0020","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"168","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dkm464","article-title":"Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15","volume":"61","author":"Nicolas-Chanoine","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2014.05.020_bib0030","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF01643429","article-title":"Fosfomycin trometamol: activity in vitro against urinary tract pathogens","volume":"18","author":"Greenwood","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1157\/13095372","article-title":"Activity of fosfomycin against extended-spectrum \u03b2-lactamase producing Escherichia coli and Klebsiella pneumoniae","volume":"24","author":"de Cueto","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0040","first-page":"68","article-title":"Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain","volume":"20","author":"Gobernado","year":"2007","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0045","first-page":"43","article-title":"Increasing prevalence of fosfomycin resistance in extended-spectrum-\u03b2-lactamase-producing Escherichia coli urinary isolates (2005\u20132009\u20132011)","volume":"26","author":"Rodr\u00edguez-Avial","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0050","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/jac\/dkq346","article-title":"Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli","volume":"65","author":"Oteo","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0055","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/jac\/dks319","article-title":"Prevalence of acquired fosfomycin resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3","volume":"67","author":"Lee","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0060","author":"International Organization for Standardization","year":"2006"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0065","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2014"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0070","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. Document M100-S21","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0075","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/jac\/dkt163","article-title":"Presence of \u03b2-lactamases in extended-spectrum-cephalosporin-resistant Salmonella enterica of 30 different serovars in Germany 2005\u201311","volume":"68","author":"Eller","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0080","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/jac\/dkp122","article-title":"Molecular epidemiology of Escherichia coli producing extended-spectrum \u03b2-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15","volume":"63","author":"Blanco","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0085","series-title":"Antimicrobial resistance surveillance in Europe 2012. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)","author":"European Centre for Disease Prevention and Control","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0090","doi-asserted-by":"crossref","first-page":"e60497","DOI":"10.1371\/journal.pone.0060497","article-title":"The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens: a Dutch Nationwide Extramural Surveillance study","volume":"8","author":"den Heijer","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s15010-007-7083-y","article-title":"Risk factor for community-acquired urinary tract infection due to quinolone-resistant E. coli","volume":"36","author":"Colodner","year":"2008","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0100","series-title":"Bericht \u00fcber den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterin\u00e4rmedizin in Deutschland","author":"GERMAP 2012","year":"2014"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00120-011-2512-z","article-title":"National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients","volume":"50","author":"Wagenlehner","year":"2011","journal-title":"Urologe A"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0110","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/AAC.06212-11","article-title":"Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high","volume":"56","author":"Jeon","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/mdr.2011.0139","article-title":"Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact","volume":"18","author":"Shin","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0120","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1128\/AAC.01993-13","article-title":"Extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli as intestinal colonizers in the German community","volume":"58","author":"Valenza","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0125","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/jac\/dkt226","article-title":"Prevalence of extended-spectrum-\u03b2-lactamase-producing Escherichia coli and spread of the epidemic clonal lineage ST131 in nursing homes in Hesse, Germany","volume":"68","author":"Arvand","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0130","series-title":"Epidemiologie und Resistenzsituation bei klinisch wichtigen Infektionserregern aus dem Hospitalbereich gegen\u00fcber Antibiotika. Bericht \u00fcber die Ergebnisse einer multizentrischen Studie der Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e.V. aus dem Jahre 2010","author":"Kresken","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0135","doi-asserted-by":"crossref","first-page":"e00377","DOI":"10.1128\/mBio.00377-13","article-title":"The epidemic of extended-spectrum-\u03b2-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx","volume":"4","author":"Price","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0140","series-title":"Arzneiverordnungs \u2013 report 2012","first-page":"311","article-title":"Antibiotika und chemotherapeutika","author":"Kern","year":"2012"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0145","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","article-title":"Biological costs and mechanisms of fosfomycin resistance in Escherichia coli","volume":"47","author":"Nilsson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.05.020_bib0150","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1469-0691.2011.03519.x","article-title":"Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting","volume":"17","author":"Kronenberg","year":"2011","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914001861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914001861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T10:55:49Z","timestamp":1538391349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914001861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0924857914001861"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.05.020","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: Extended-spectrum \u03b2-lactamases and the role of fosfomycin","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}